Walvax BioTech (300142): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 13,09 Renminbi Yuan | 16,97 Renminbi Yuan | 10,743 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.599.348.541 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 2.410.266,571 | 2.821.441,301 | 4.113.772,326 | 5.086.445,194 | 3.462.831,093 | 2.939.021,218 | 1.121.220,288 | 874.320,102 | 668.264,841 | 591.004,603 | 1.006.027,016 | 719.021,31 | 583.094,756 | 537.558,541 | 470.174,507 | 358.792,291 | 239.129,713 | 184.061,893 | 129.361,532 |
Cashflow aus operativer Geschäftstätigkeit | 494.370,55 | 1.036.524,527 | 1.133.768,797 | 1.201.491,008 | 705.276,75 | 114.192,983 | 62.016,82 | -65.228,373 | -10.129,484 | -89.937,061 | -69.412,675 | -65.933,088 | -121.732,126 | 78.380,602 | 91.977,915 | 86.711,202 | 82.184,376 | -5.694,618 | 31.845,105 |
▸ Operative Cashflow Marge | 20,51% | 36,74% | 27,56% | 23,62% | 20,37% | 3,89% | 5,53% | -7,46% | -1,52% | -15,22% | -6,9% | -9,17% | -20,88% | 14,58% | 19,56% | 24,17% | 34,37% | -3,09% | 24,62% |
Investitionsausgaben (CapEx) | 509.544,94 | 550.029,879 | 945.515,599 | 1.091.176,917 | 1.103.484,299 | 407.131,203 | 351.823,051 | 227.322,169 | 331.061,683 | 250.235,987 | 264.747,763 | 240.393,047 | 389.670,623 | 355.867,241 | 197.560,325 | 164.814,366 | 74.754,257 | 29.390,26 | 18.256,445 |
Cashflow aus Investitionstätigkeit | -2.009.694,274 | -1.266.667,07 | -810.278,299 | -935.186,37 | -977.149,844 | -729.999,706 | 192.996,355 | 619.137,183 | -14.435,774 | 110.562,932 | -451.160,061 | -250.317,827 | -1.429.128,995 | -1.065.822,959 | -209.257,893 | -164.808,526 | -77.244,575 | -39.390,26 | -18.176,003 |
Cashflow aus Finanzierungstätigkeit | -894.583,153 | -371.030,642 | 236.643,942 | 94.818,121 | 1.736.440,477 | 215.077,607 | -360.637,297 | 711.699,349 | -188.995,869 | 401.577,876 | 928.946,657 | -329.499,451 | 1.358.230,941 | 416.430,111 | -229.119,018 | 2.338.571,638 | 51.007,474 | 42.247,746 | 4.704,552 |
Freier Cashflow | -15.174,39 | 486.494,649 | 188.253,198 | 110.314,091 | -398.207,549 | -292.938,22 | -289.806,231 | -292.550,542 | -341.191,167 | -340.173,048 | -334.160,438 | -306.326,136 | -511.402,749 | -277.486,639 | -105.582,41 | -78.103,164 | 7.430,119 | -35.084,878 | 13.588,66 |
▸ Freie Cashflow Marge | -0,63% | 17,24% | 4,58% | 2,17% | -11,5% | -9,97% | -25,85% | -33,46% | -51,06% | -57,56% | -33,22% | -42,6% | -87,7% | -51,62% | -22,46% | -21,77% | 3,11% | -19,06% | 10,5% |
Ausgeschüttete Dividenden | -28.993,834 | -40.940,003 | -15.993,485 | -50.111,222 | -78.309,349 | -30.869,039 | -68.682,305 | -4.454,605 | -34.313,255 | -126.127,235 | -154.672,36 | -173.967,617 | -98.306,961 | -58.755,142 | -48.904,074 | -4.500,516 | -3.830,055 | -3.951,919 | -2.040,947 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | -72.212,929 | -286.416,643 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.